Protein Variants | Comment | Organism |
---|---|---|
L158P | site-directed mutagenesis, introducetion of a Leu157Pro substitution into the Chlamydomonas ND4 subunit of complex I in two recipient strains by biolistic transformation | Chlamydomonas sp. |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
mitochondrion | - |
Homo sapiens | 5739 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Chlamydomonas sp. | - |
- |
- |
Homo sapiens | - |
- |
- |
Synonyms | Comment | Organism |
---|---|---|
complex I | - |
Homo sapiens |
complex I | - |
Chlamydomonas sp. |
NADH:ubiquinone oxidoreductase | - |
Homo sapiens |
NADH:ubiquinone oxidoreductase | - |
Chlamydomonas sp. |
Cofactor | Comment | Organism | Structure |
---|---|---|---|
NADH | - |
Homo sapiens |
General Information | Comment | Organism |
---|---|---|
malfunction | defects in complex I are the most frequent cause of human respiratory disorders. Substitution L158P does not lead to any respiratory enzyme defects when present in the heteroplasmic state in a patient with chronic progressive external ophthalmoplegia | Homo sapiens |
malfunction | when present in the homoplasmic state in the alga, the mutation does not prevent assembly of the whole complex I, the NADH dehydrogenase activity of the peripheral arm of the complex is mildly affected. The NADH:duroquinone oxidoreductase activity is strongly reduced, suggesting that the substitution could affect binding of ubiquinone to the membrane domain. The membrane potential is not affected in mutant mitochondria. The in vitro defects correlate with a decrease in dark respiration and growth rate in vivo, phenotype, overview | Chlamydomonas sp. |